HomeCompareEMN vs HRC

EMN vs HRC: Dividend Comparison 2026

EMN yields 4.60% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRC wins by $2.19M in total portfolio value
10 years
EMN
EMN
● Live price
4.60%
Share price
$72.55
Annual div
$3.34
5Y div CAGR
25.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62.5K
Annual income
$11,712.17
Full EMN calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — EMN vs HRC

📍 HRC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMNHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMN + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMN pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMN
Annual income on $10K today (after 15% tax)
$391.32/yr
After 10yr DRIP, annual income (after tax)
$9,955.34/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, HRC beats the other by $1,199,959.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMN + HRC for your $10,000?

EMN: 50%HRC: 50%
100% HRC50/50100% EMN
Portfolio after 10yr
$1.16M
Annual income
$717,570.91/yr
Blended yield
61.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EMN right now

EMN
Analyst Ratings
20
Buy
14
Hold
1
Sell
Consensus: Buy
Price Target
$74.00
+2.0% upside vs current
Range: $70.00 — $79.00
Altman Z
2.3
Piotroski
6/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMN buys
0
HRC buys
0
No recent congressional trades found for EMN or HRC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMNHRC
Forward yield4.60%11.38%
Annual dividend / share$3.34$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR25.7%40.3%
Portfolio after 10y$62.5K$2.26M
Annual income after 10y$11,712.17$1,423,429.65
Total dividends collected$36.8K$2.14M
Payment frequencyquarterlyquarterly
SectorMaterialsStock
Analyst consensusBuyHold

Year-by-year: EMN vs HRC ($10,000, DRIP)

YearEMN PortfolioEMN Income/yrHRC PortfolioHRC Income/yrGap
1← crossover$11,279$578.69$12,296$1,595.93$1.0KHRC
2$12,835$766.75$15,730$2,573.05$2.9KHRC
3$14,758$1,025.04$21,147$4,316.00$6.4KHRC
4$17,176$1,384.65$30,235$7,608.15$13.1KHRC
5$20,272$1,893.11$46,615$14,263.36$26.3KHRC
6$24,315$2,624.76$78,712$28,834.27$54.4KHRC
7$29,716$3,698.58$148,063$63,841.01$118.3KHRC
8$37,106$5,310.02$315,890$157,462.80$278.8KHRC
9$47,493$7,789.38$778,498$440,495.17$731.0KHRC
10$62,530$11,712.17$2,256,422$1,423,429.65$2.19MHRC

EMN vs HRC: Complete Analysis 2026

EMNMaterials

Eastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; heat transfer and aviation fluids; insoluble sulfur and anti-degradant rubber additives; and performance resins. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables, and electronics markets. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, cellulose esters, polyvinyl butyral (PVB) sheets, and window and protective films, and aftermarket applied film products for value-added end uses in the transportation, durables, electronics, building and construction, medical and pharma, and consumables markets. The company's Chemical Intermediates segment offers methylamines and salts higher amines and solvents; Olefin and acetyl derivatives, ethylene, and commodity solvents; and primary non-phthalate and phthalate plasticizers, and niche non- phthalate plasticizers to the industrial chemicals and processing, building and construction, health and wellness, and agrochemicals. Its Fibers segment provides cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride for use in filtration media primarily cigarette filters; natural and solution dyed acetate yarns for use in consumables, and health and wellness markets; and wet-laid nonwoven media, specialty and engineered papers, and cellulose acetate fibers for transportation, industrial, agriculture and mining, and aerospace markets. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.

Full EMN Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this EMN vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMN vs SCHDEMN vs JEPIEMN vs OEMN vs KOEMN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.